The human brain has its own cleaning system. Every day, waste products and damaged proteins are removed to keep brain cells healthy and functioning properly.
When this cleaning system breaks down, harmful materials can accumulate and damage the brain. Scientists believe this failure may play an important role in Alzheimer’s disease.
Alzheimer’s disease is the most common type of dementia. It affects memory, thinking, language, and behavior. More than just occasional forgetfulness, the disease slowly destroys brain cells and eventually interferes with almost every aspect of daily life. As people live longer, Alzheimer’s disease has become one of the world’s fastest-growing health problems.
One of the hallmarks of Alzheimer’s disease is the buildup of amyloid-beta, a sticky protein that forms plaques inside the brain. These plaques are believed to contribute to inflammation, disrupt communication between brain cells, and eventually lead to cell death.
Under normal conditions, amyloid-beta does not simply remain inside the brain. The body has mechanisms to remove it. A major part of this system is the blood-brain barrier, a protective layer that separates the brain from the rest of the body’s circulation.
The blood-brain barrier is often described as a security gate. It carefully controls what enters and leaves the brain. Embedded within this barrier are tiny transport proteins called P-glycoprotein pumps. These pumps help move harmful waste products, including amyloid-beta, out of the brain and into the bloodstream for disposal.
Researchers have discovered that these pumps become much weaker in Alzheimer’s disease. As their function declines, amyloid-beta can accumulate and gradually clog the brain’s waste-removal system.
Scientists at Monash University have now found evidence that a copper-containing compound called Cu(ATSM) may help restore this important cleaning process. Their study was published in ACS Chemical Neuroscience.
Cu(ATSM) has attracted scientific interest because it can deliver copper to the brain. Copper is an essential mineral that helps many enzymes function properly and supports energy production within cells. Scientists suspect that abnormalities in copper handling may contribute to several neurological diseases.
In the new study, researchers tested Cu(ATSM) in laboratory models of Alzheimer’s disease. The treatment increased the number of waste-clearing pumps in the blood-brain barrier by approximately 24 percent.
As the pumps became more active, the brain was able to remove more amyloid-beta. After 56 days of treatment, toxic protein levels had fallen by 42 percent.
The researchers also examined whether these changes translated into better brain function. Encouragingly, they found improvements in long-term spatial memory. The treated animals showed almost 44 percent better performance in tasks involving learning and remembering locations.
Lead author Dr. Jae Pyun explained that this is the first study to demonstrate that repairing the blood-brain barrier’s transport system can reduce toxic proteins while simultaneously improving cognitive performance.
The researchers believe that several processes may be involved. They suspect that the copper treatment may not only repair waste-clearing pumps but may also help the brain’s immune cells, known as microglia, become better at consuming and breaking down harmful plaques.
Another reason the findings are attracting attention is that Cu(ATSM) has already undergone safety evaluations for other neurological diseases, including Parkinson’s disease and ALS. This previous work may make it easier to move toward clinical testing in Alzheimer’s patients.
Professor Joseph Nicolazzo, who led the research team at the Monash Institute of Pharmaceutical Sciences, said that lowering amyloid burden has already been linked with improved outcomes in patients. Therefore, the new findings provide a strong scientific reason to investigate the compound further.
The study also highlights an important shift in Alzheimer’s research. Many experimental treatments have focused directly on destroying amyloid plaques. In contrast, this approach attempts to repair the brain’s natural cleaning mechanisms and help the brain remove toxic proteins by itself.
The study has several strengths. It measured both biological changes and memory performance, and it identified a potentially practical treatment because the compound has already been tested in other diseases.
However, there are also limitations. The research remains at a preclinical stage, meaning it was conducted in laboratory models rather than in people. Scientists also still need to understand exactly how the proteins travel out of the brain after treatment.
Overall, the findings open an intriguing new direction for Alzheimer’s therapy. Instead of focusing only on the toxic proteins themselves, researchers are asking whether repairing the brain’s waste-disposal system may help slow or prevent cognitive decline.
Although much more research is needed, the study offers hope that strengthening the brain’s own cleaning abilities could one day become part of the fight against Alzheimer’s disease.
If you care about Alzheimer’s disease, please read studies about the protective power of dietary antioxidants against Alzheimer’s, and eating habits linked to higher Alzheimer’s risk.
For more health information, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Source: Monash University.
